Literature DB >> 21115163

Genetics of pheochromocytomas and paragangliomas.

Giuseppe Opocher1, Francesca Schiavi.   

Abstract

Pheochromocytoma and paraganglioma are tumors of the sympathetic or parasympathetic paraganglia. Pheochromocytoma is the tumor of the main sympathetic paraganglia, which is the adrenal medulla. The sympathetic paraganglioma secretes catecholamine while the parasympathetic do not. Both of them originate from neural crest cells and share similar mechanisms of tumor development. The same genetic alteration may predispose to the development of sympathetic and parasympathetic paraganglioma. The best known hereditary forms of pheochromocytoma and paraganglioma are the von Hippel-Lindau disease, in which pheochromocytoma may be associated with CNS hemangioblastoma, retinal angioma, pancreatic endocrine tumor/cysts and renal clear cell carcinoma/cysts; the multiple endocrine neoplasia type 2, in which pheochromocytoma is associated with medullary thyroid carcinoma and primary hyperparathyroidism, Type 1 neurofibromatosis, the most frequent hereditary cancer syndrome. Finally, it has been characterized the paraganglioma syndrome in which sympathetic and parasympathetic paraganglioma are variously associated. The list of predisposing gene is quite long and comprises VHL, RET, NF1, SDHB, SDHC, SDHD, SDHAF2. More rarely, two other genes may predispose to pheochromocytoma/paraganglioma development: KIF1Bbeta and PHD2. A mechanism conducing to a defective apoptosis is the common pathways of those genes. Finally, there is also good evidence of the role of other genes, not yet completely identified. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21115163     DOI: 10.1016/j.beem.2010.05.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  21 in total

Review 1.  An update on the genetics of pheochromocytoma.

Authors:  D Karasek; U Shah; Z Frysak; C Stratakis; K Pacak
Journal:  J Hum Hypertens       Date:  2012-05-31       Impact factor: 3.012

Review 2.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

3.  Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma.

Authors:  Matthew G Dudgeon; Sushilkumar K Sonavane; Ephraim E Parent; Andras Khoor; Mathew Thomas
Journal:  J Radiol Case Rep       Date:  2020-10-31

4.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

5.  Case - Bladder paraganglioma in a pediatric patient.

Authors:  Armaan K Malhotra; Ryan Yan; Raymond Tabeshi; Helen Nadel; Henry Tran; John Masterson
Journal:  Can Urol Assoc J       Date:  2018-02-06       Impact factor: 1.862

6.  A novel SDHB mutation associated with hereditary head and neck paraganglioma.

Authors:  Brandon W Peck; Thereasa A Rich; Camilo Jimenez; Michael E Kupferman
Journal:  Laryngoscope       Date:  2011-12       Impact factor: 3.325

7.  [Rare forms of hypertension : From pheochromocytoma to vasculitis].

Authors:  H Haller; F Limbourg; B M Schmidt; J Menne
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

8.  Mutation screening in a Norwegian cohort with pheochromocytoma.

Authors:  Wenche Sjursen; Henrik Halvorsen; Eva Hofsli; Siri Bachke; Asa Berge; Lars F Engebretsen; Sture E Falkmer; Ursula G Falkmer; Jan E Varhaug
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 9.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

10.  Incidental Diagnosis of Multiple Paragangliomas by Ga-68 DOTANOC Positron Emission Tomography-Computed Tomography.

Authors:  Vivek Kumar Saini; Akshay Kumar; Aftab Hasan Nazar; Manish Ora; Sanjay Gambhir
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.